BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Bluejay Diagnostics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.70−0.05 (-6.46%)
Close on Oct 19, 2026
- Market cap
- $1.45M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Mar 6, 2026(first seen in filings) | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Jan 29, 2026 | 1-for-4 reverse | Earlier per-share figures multiplied by 4 |
| Mar 31, 2025(first seen in filings) | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Nov 18, 2024 | 1-for-50 reverse | Earlier per-share figures multiplied by 50 |
| Aug 14, 2024(first seen in filings) | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Jun 20, 2024 | 1-for-8 reverse | Earlier per-share figures multiplied by 8 |
| Aug 14, 2023(first seen in filings) | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |
| Jul 24, 2023 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |